Results 21 to 30 of about 2,696 (177)

A New Case of Granulomatosis with Polyangiitis Presented with Tolosa-Hunt Syndrome Manifestations. [PDF]

open access: yesCase Rep Rheumatol
Background. Tolosa–Hunt syndrome (THS) is a rare disorder involving the orbital and retro‐orbital space. The typical symptoms include sensory loss in the trigeminal nerve’s distribution, orbital pain, swelling, headaches, and cranial nerve palsies. Case Presentation.
Mohebbi M, Nafissi S, Alikhani M.
europepmc   +2 more sources

Total remission of Tolosa-Hunt Syndrome with single-dose of infliximab [PDF]

open access: yesRevista Brasileira de Oftalmologia, 2020
Tolosa-Hunt syndrome is a painful ophthalmoplegia caused by non-specific granulomatous inflammation, corticoid-sensitive, of the cavernous sinus. The etiology is unknown. Recurrences are common.
Luís Armando Vitorino Alves de Souza Gondim   +4 more
doaj   +1 more source

GLANZMANNS THROMBASTHENIA [PDF]

open access: yesBasrah Journal of Surgery, 2009
Tolosa-Hunt syndrome (THS) has been described as a painful, unilateral, partial or total ophthalmoplegia caused by a nonspecific granulomatous process in the cavernous sinus, the superior orbital fissure, or the orbital apex.
ZUHAIR AL-BARAZANCHImad
doaj   +1 more source

A CPH-Like Picture in Two Patients with an Orbitocavernous Sinus Syndrome [PDF]

open access: yes, 1997
Two patients with retroorbital pain syndromes with or without paresis of cranial nerves developed weeks after ipsilateral headache resembling chronic paroxysmal hemicrania (CPH) but without autonomic features.
A Straube   +5 more
core   +1 more source

Clinical insights on Tolosa Hunt syndrome: a multidisciplinary approach on neurological-related symptomatology in maxillofacial region [PDF]

open access: yes, 2018
Background Tolosa–Hunt syndrome (THS) related neurological symptoms are described in literature as “unilateral”, “recurrent”, “episodic”, “intense”, “severe”, “lancinating” or “stabbing” pain on the upper face and forehead and may be misdiagnosed ...
Ahmed Siddiqui, Ammar   +8 more
core   +2 more sources

Great masquerader in Pandora's box: A case of orbital TB

open access: yesTNOA Journal of Ophthalmic Science and Research, 2023
Orbital tuberculosis is rare, even in endemic areas. A 45-year-old male diabetic presented with drooping of the right eyelid and facial pain for one month.
Venipriya Sigamani   +3 more
doaj   +1 more source

Tolosa Hunt Syndrome: A Case Report [PDF]

open access: yesDüşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2006
Introduction: Tolosa Hunt syndrome is an idiopathic inflammation localised in the apex of the orbita, cavernous sinus and superior orbital fissura. Clinical presentation is orbital or periorbital pain, followed by cranial nevre paresis.
Belgin Mutluay   +4 more
doaj   +3 more sources

Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex

open access: yesClinical Case Reports, Volume 11, Issue 1, January 2023., 2023
Abstract Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen‐specific antinociceptive effect in the treatment of histamine‐mediated pain.
Hyuk Soon Kim, Geunwoong Noh
wiley   +1 more source

Rôle de la corticothérapie systémique dans le syndrome de Tolosa-Hunt

open access: yesJournal de la Société Marocaine d’Ophtalmologie, 2017
Introduction : Le syndrome de Tolosa-Hunt, décrit est une inflammation non spécifique des septas et du toit du sinus caverneux. Ce syndrome clinique reste une entité rare, dont les mécanismes physiopathologiques sont encore mal élucidés.
G. Bouayad   +8 more
doaj   +1 more source

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network [PDF]

open access: yes, 2013
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
A Bashey   +88 more
core   +4 more sources

Home - About - Disclaimer - Privacy